Cohort profile: Patient characteristics and quality-of-life measurements for newly-referred patients with atrial fibrillation - Keio interhospital Cardiovascular Studies-atrial fibrillation (KiCS-AF)

Nobuhiro Ikemura, John A. Spertus, Takehiro Kimura, Kenneth Mahaffey, Jonathan P. Piccini, Taku Inohara, Ikuko Ueda, Kojiro Tanimoto, Masahiro Suzuki, Iwao Nakamura, Makoto Akaishi, Hideo Mitamura, Keiichi Fukuda, Seiji Takatsuki, Shun Kohsaka

Research output: Contribution to journalArticle

Abstract

Purpose Besides the high rates of morbidity and mortality, atrial fibrillation (AF) is also associated with impairment of quality-of-life (QOL). However, reports covering non-selected AF population within Asian countries remain scarce. The objective of the Keio interhospital Cardiovascular Studies-atrial fibrillation (KiCS-AF) registry is to clarify the baseline and QOL profiles of the AF patients at the time of initial referral to identify areas for improvement and country-specific gaps. Participants: The KiCS-AF registry is a multicentre, prospective cohort study designed to specifically recruit AF patients newly referred to the 11 network hospitals within the Kanto area of Japan. The registry completed its enrolment in June 2018. All patients were requested to answer the Atrial Fibrillation Effect on Quality-of-Life (AFEQT) questionnaire both at baseline and 1 year, with planned clinical follow-up for 5 years. The registry also assessed individual treatment strategies including rate and rhythm control, stroke prophylaxis, and their impacts on patient-reported QOL. Findings to date: As of December 2016, 2464 AF patients were registered; their mean age was 67.1 years (SD, 11.7), majority (69.7%; n=1717) were men and 49.2% presented with paroxysmal AF. The mean CHA2DS2-VASc (cardiac failure or dysfunction, hypertension, age ≥75 years, diabetes, stroke including vascular disease, age 65-74 years, and sex category [female]) score was 2.3 (SD, 1.6) and oral anticoagulant therapy was used for 88.6% of patients with CHA2DS2-VASc scores ≥2. The median AFEQT-overall summary score was 79.1 (IQR, 66.6-89.1). Roughly 50% had significantly impaired QOL (ie, AFEQT <80) at baseline. Currently, 2307 eligible patients (93.6%) have completed the 1-year follow-up, of which 2072 patients (89.8%) answered the second AFEQT questionnaire. Future plans The KiCS-AF allowed for extensive investigation of AF-related QOL in a non-selected population with long-term follow-up using a rigorously validated QOL assessment tool. Almost half of patients had impaired QOL at baseline. Further investigations aimed at providing care and improving patient-reported QOL are required.

Original languageEnglish
Article numbere032746
JournalBMJ open
Volume9
Issue number12
DOIs
Publication statusPublished - 2019 Dec 18

Fingerprint

Atrial Fibrillation
Quality of Life
Registries
Stroke
Vascular Diseases
Anticoagulants
Population
Patient Care
Japan
Cohort Studies
Referral and Consultation
Heart Failure
Prospective Studies
Hypertension
Morbidity

Keywords

  • adult cardiology
  • pacing & electrophysiology
  • quality in health care

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cohort profile : Patient characteristics and quality-of-life measurements for newly-referred patients with atrial fibrillation - Keio interhospital Cardiovascular Studies-atrial fibrillation (KiCS-AF). / Ikemura, Nobuhiro; Spertus, John A.; Kimura, Takehiro; Mahaffey, Kenneth; Piccini, Jonathan P.; Inohara, Taku; Ueda, Ikuko; Tanimoto, Kojiro; Suzuki, Masahiro; Nakamura, Iwao; Akaishi, Makoto; Mitamura, Hideo; Fukuda, Keiichi; Takatsuki, Seiji; Kohsaka, Shun.

In: BMJ open, Vol. 9, No. 12, e032746, 18.12.2019.

Research output: Contribution to journalArticle

Ikemura, Nobuhiro ; Spertus, John A. ; Kimura, Takehiro ; Mahaffey, Kenneth ; Piccini, Jonathan P. ; Inohara, Taku ; Ueda, Ikuko ; Tanimoto, Kojiro ; Suzuki, Masahiro ; Nakamura, Iwao ; Akaishi, Makoto ; Mitamura, Hideo ; Fukuda, Keiichi ; Takatsuki, Seiji ; Kohsaka, Shun. / Cohort profile : Patient characteristics and quality-of-life measurements for newly-referred patients with atrial fibrillation - Keio interhospital Cardiovascular Studies-atrial fibrillation (KiCS-AF). In: BMJ open. 2019 ; Vol. 9, No. 12.
@article{95c4c3452790418b9cf2832a00338d13,
title = "Cohort profile: Patient characteristics and quality-of-life measurements for newly-referred patients with atrial fibrillation - Keio interhospital Cardiovascular Studies-atrial fibrillation (KiCS-AF)",
abstract = "Purpose Besides the high rates of morbidity and mortality, atrial fibrillation (AF) is also associated with impairment of quality-of-life (QOL). However, reports covering non-selected AF population within Asian countries remain scarce. The objective of the Keio interhospital Cardiovascular Studies-atrial fibrillation (KiCS-AF) registry is to clarify the baseline and QOL profiles of the AF patients at the time of initial referral to identify areas for improvement and country-specific gaps. Participants: The KiCS-AF registry is a multicentre, prospective cohort study designed to specifically recruit AF patients newly referred to the 11 network hospitals within the Kanto area of Japan. The registry completed its enrolment in June 2018. All patients were requested to answer the Atrial Fibrillation Effect on Quality-of-Life (AFEQT) questionnaire both at baseline and 1 year, with planned clinical follow-up for 5 years. The registry also assessed individual treatment strategies including rate and rhythm control, stroke prophylaxis, and their impacts on patient-reported QOL. Findings to date: As of December 2016, 2464 AF patients were registered; their mean age was 67.1 years (SD, 11.7), majority (69.7{\%}; n=1717) were men and 49.2{\%} presented with paroxysmal AF. The mean CHA2DS2-VASc (cardiac failure or dysfunction, hypertension, age ≥75 years, diabetes, stroke including vascular disease, age 65-74 years, and sex category [female]) score was 2.3 (SD, 1.6) and oral anticoagulant therapy was used for 88.6{\%} of patients with CHA2DS2-VASc scores ≥2. The median AFEQT-overall summary score was 79.1 (IQR, 66.6-89.1). Roughly 50{\%} had significantly impaired QOL (ie, AFEQT <80) at baseline. Currently, 2307 eligible patients (93.6{\%}) have completed the 1-year follow-up, of which 2072 patients (89.8{\%}) answered the second AFEQT questionnaire. Future plans The KiCS-AF allowed for extensive investigation of AF-related QOL in a non-selected population with long-term follow-up using a rigorously validated QOL assessment tool. Almost half of patients had impaired QOL at baseline. Further investigations aimed at providing care and improving patient-reported QOL are required.",
keywords = "adult cardiology, pacing & electrophysiology, quality in health care",
author = "Nobuhiro Ikemura and Spertus, {John A.} and Takehiro Kimura and Kenneth Mahaffey and Piccini, {Jonathan P.} and Taku Inohara and Ikuko Ueda and Kojiro Tanimoto and Masahiro Suzuki and Iwao Nakamura and Makoto Akaishi and Hideo Mitamura and Keiichi Fukuda and Seiji Takatsuki and Shun Kohsaka",
year = "2019",
month = "12",
day = "18",
doi = "10.1136/bmjopen-2019-032746",
language = "English",
volume = "9",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "BMJ Publishing Group",
number = "12",

}

TY - JOUR

T1 - Cohort profile

T2 - Patient characteristics and quality-of-life measurements for newly-referred patients with atrial fibrillation - Keio interhospital Cardiovascular Studies-atrial fibrillation (KiCS-AF)

AU - Ikemura, Nobuhiro

AU - Spertus, John A.

AU - Kimura, Takehiro

AU - Mahaffey, Kenneth

AU - Piccini, Jonathan P.

AU - Inohara, Taku

AU - Ueda, Ikuko

AU - Tanimoto, Kojiro

AU - Suzuki, Masahiro

AU - Nakamura, Iwao

AU - Akaishi, Makoto

AU - Mitamura, Hideo

AU - Fukuda, Keiichi

AU - Takatsuki, Seiji

AU - Kohsaka, Shun

PY - 2019/12/18

Y1 - 2019/12/18

N2 - Purpose Besides the high rates of morbidity and mortality, atrial fibrillation (AF) is also associated with impairment of quality-of-life (QOL). However, reports covering non-selected AF population within Asian countries remain scarce. The objective of the Keio interhospital Cardiovascular Studies-atrial fibrillation (KiCS-AF) registry is to clarify the baseline and QOL profiles of the AF patients at the time of initial referral to identify areas for improvement and country-specific gaps. Participants: The KiCS-AF registry is a multicentre, prospective cohort study designed to specifically recruit AF patients newly referred to the 11 network hospitals within the Kanto area of Japan. The registry completed its enrolment in June 2018. All patients were requested to answer the Atrial Fibrillation Effect on Quality-of-Life (AFEQT) questionnaire both at baseline and 1 year, with planned clinical follow-up for 5 years. The registry also assessed individual treatment strategies including rate and rhythm control, stroke prophylaxis, and their impacts on patient-reported QOL. Findings to date: As of December 2016, 2464 AF patients were registered; their mean age was 67.1 years (SD, 11.7), majority (69.7%; n=1717) were men and 49.2% presented with paroxysmal AF. The mean CHA2DS2-VASc (cardiac failure or dysfunction, hypertension, age ≥75 years, diabetes, stroke including vascular disease, age 65-74 years, and sex category [female]) score was 2.3 (SD, 1.6) and oral anticoagulant therapy was used for 88.6% of patients with CHA2DS2-VASc scores ≥2. The median AFEQT-overall summary score was 79.1 (IQR, 66.6-89.1). Roughly 50% had significantly impaired QOL (ie, AFEQT <80) at baseline. Currently, 2307 eligible patients (93.6%) have completed the 1-year follow-up, of which 2072 patients (89.8%) answered the second AFEQT questionnaire. Future plans The KiCS-AF allowed for extensive investigation of AF-related QOL in a non-selected population with long-term follow-up using a rigorously validated QOL assessment tool. Almost half of patients had impaired QOL at baseline. Further investigations aimed at providing care and improving patient-reported QOL are required.

AB - Purpose Besides the high rates of morbidity and mortality, atrial fibrillation (AF) is also associated with impairment of quality-of-life (QOL). However, reports covering non-selected AF population within Asian countries remain scarce. The objective of the Keio interhospital Cardiovascular Studies-atrial fibrillation (KiCS-AF) registry is to clarify the baseline and QOL profiles of the AF patients at the time of initial referral to identify areas for improvement and country-specific gaps. Participants: The KiCS-AF registry is a multicentre, prospective cohort study designed to specifically recruit AF patients newly referred to the 11 network hospitals within the Kanto area of Japan. The registry completed its enrolment in June 2018. All patients were requested to answer the Atrial Fibrillation Effect on Quality-of-Life (AFEQT) questionnaire both at baseline and 1 year, with planned clinical follow-up for 5 years. The registry also assessed individual treatment strategies including rate and rhythm control, stroke prophylaxis, and their impacts on patient-reported QOL. Findings to date: As of December 2016, 2464 AF patients were registered; their mean age was 67.1 years (SD, 11.7), majority (69.7%; n=1717) were men and 49.2% presented with paroxysmal AF. The mean CHA2DS2-VASc (cardiac failure or dysfunction, hypertension, age ≥75 years, diabetes, stroke including vascular disease, age 65-74 years, and sex category [female]) score was 2.3 (SD, 1.6) and oral anticoagulant therapy was used for 88.6% of patients with CHA2DS2-VASc scores ≥2. The median AFEQT-overall summary score was 79.1 (IQR, 66.6-89.1). Roughly 50% had significantly impaired QOL (ie, AFEQT <80) at baseline. Currently, 2307 eligible patients (93.6%) have completed the 1-year follow-up, of which 2072 patients (89.8%) answered the second AFEQT questionnaire. Future plans The KiCS-AF allowed for extensive investigation of AF-related QOL in a non-selected population with long-term follow-up using a rigorously validated QOL assessment tool. Almost half of patients had impaired QOL at baseline. Further investigations aimed at providing care and improving patient-reported QOL are required.

KW - adult cardiology

KW - pacing & electrophysiology

KW - quality in health care

UR - http://www.scopus.com/inward/record.url?scp=85077047774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077047774&partnerID=8YFLogxK

U2 - 10.1136/bmjopen-2019-032746

DO - 10.1136/bmjopen-2019-032746

M3 - Article

C2 - 31857312

AN - SCOPUS:85077047774

VL - 9

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 12

M1 - e032746

ER -